Statins and sepsis: multiple modifications at multiple levels.
about
Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsisIn the critically ill patient, diabetes predicts mortality independent of statin therapy but is not associated with acute lung injury: a cohort studyStatins decrease neuroinflammation and prevent cognitive impairment after cerebral malariaCommentary: From scarcity to abundance: pandemic vaccines and other agents for "have not" countriesIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesConfronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work.Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) diseaseStatins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell diseaseStatins and outcomes in patients with bloodstream infection: a propensity-matched analysis.GTPase activating protein function of p85 facilitates uptake and recycling of the beta1 integrinImpact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational studyPreadmission statin use and one-year mortality among patients in intensive care - a cohort study.Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.Association between statin therapy and outcomes in critically ill patients: a nested cohort study.Statins and postoperative infections: a randomized clinical trialSimvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation.Rosuvastatin for sepsis-associated acute respiratory distress syndromeThe influence of statin exposure on inflammatory markers in patients with early bacterial infection: pilot prospective cohort study.Effect of statin use on outcomes of adults with candidemia.Effect of beta-blocker therapy on the risk of infections and death after acute stroke--a historical cohort studyThe association between donor and recipient statin use and infections after allogeneic hematopoietic cell transplantation.Novel simvastatin inhalation formulation and characterisationPrior statin use and 90-day mortality in Gram-negative and Gram-positive bloodstream infection: a prospective observational study.Statins and brain dysfunction: a hypothesis to reduce the burden of cognitive impairment in patients who are critically illRisk of pneumonia in patients taking statins: population-based nested case-control study.Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort studyDrug Repurposing Screen Identifies Foxo1-Dependent Angiopoietin-2 Regulation in Sepsis.Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis: comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin.Host cell invasion by Staphylococcus aureus stimulates the shedding of microvesicles.Coenzyme Q10 levels are low and may be associated with the inflammatory cascade in septic shock.Simvastatin is protective during Staphylococcus aureus pneumoniaAtorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model.Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin.Statins in the critically illDisruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitisBeneficial effects of perioperative statins for major pulmonary resection.The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort study.Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial.Risk factors for acute organ failure in intensive care unit patients who receive respiratory support in the absence of non-respiratory organ failure: an international prospective cohort studyCytokines and lipopolysaccharides induce inducible nitric oxide synthase but not enzyme activity in adult rat cardiomyocytes.
P2860
Q24193361-2543C1D6-35D7-4E37-950A-AEA8F6F15533Q24601189-9796FCD3-1DC3-45B5-9979-C87C2A249CD4Q27338288-3F355E60-8CFB-41D9-BD17-2BE21B3371A9Q28242054-912B68E7-ACC4-47EE-8806-E9B2A9103AB5Q28388335-416269B8-1E87-46EB-A2AB-821C907F4C6EQ30379206-AD68542A-7D0B-4E33-822E-5D2C7ED32F60Q30402302-2DBD6C2F-5260-46C9-A054-B26BFB3E02D2Q30492867-17E7D43D-3270-4170-BA4E-485F905AD966Q30534785-B0B243B5-B993-49F6-9472-B4C603799892Q33615852-7286D877-7492-4C76-A01A-F4E6A09E6FBDQ33821978-50336209-B6BF-4574-B0BA-8F11A04420B5Q33919029-7077EA1A-E2B6-4097-BBF7-AA81384D29A4Q33941922-D556F3A3-076C-4369-AD72-B99E8CEABACFQ33984047-FA1DADFA-2B3C-440F-8224-3096BFC9E427Q34068550-047B7272-32A6-4E2D-9977-B49C8FD96829Q34305806-B6C8580F-7239-46D6-8A7E-BDD5C4A73954Q34559446-DB9FBD06-59E3-41DF-BFA5-C0702C303B45Q34636358-A394ACC0-38E3-4E84-BD96-0B8F1925964DQ35025431-F4D0E996-532A-48F1-A26F-C04F5DC58B69Q35038824-C2F39E61-632B-4DDD-AB15-74A01A68E902Q35152144-BB51FE8E-448D-4C28-AA80-8262B62A3D83Q35164779-F7AD3622-166D-41ED-88D6-7DAC6684C57BQ35169285-48C224F8-F3D3-41FE-969E-7DD77234D20DQ35201872-58A6A3F7-FC4B-4A43-BA82-8BF21DF676D7Q35511988-476D8F82-B47A-47DA-93DC-55717D77F5BDQ35567062-96CCE8D7-424B-4305-B34E-5BC3676B6681Q35597977-13C7B5FC-04E1-4CE0-A663-6D70797E4D38Q35603020-7D237D68-4BAB-4EBB-9F10-F20597E03A7AQ35695065-A2B8EEEB-F4F0-4089-98E3-81CF2E3CAEE8Q35733679-A96C7B17-5B84-43D9-BB1E-35C87B7C94C9Q35747672-7D8E0F21-2CB5-4DD9-BA92-4832D268EB8EQ35753471-33ED65AE-D855-4AE9-93C7-8E9E4D8CE445Q36127865-5BD9E5C1-5787-40C8-9AA4-60FA7BA9094AQ36369699-58353024-68A3-41B5-8049-8D4758683BF9Q36517801-4FE7908B-9EEF-4FB4-8655-A008E7AAD09CQ36593127-ED149674-F1B9-4B84-8E29-EC6411277BEAQ36633863-79464D09-AC91-4FBD-991D-83BC1C128087Q36689726-ADDD3AB1-E2A4-4C0B-8A6F-7D209E9B2548Q36925841-231D0C12-E1E4-49CE-8500-9CEE017A5B37Q36962909-2E74B59D-54AC-44AA-BF98-1542117D778B
P2860
Statins and sepsis: multiple modifications at multiple levels.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Statins and sepsis: multiple modifications at multiple levels.
@en
type
label
Statins and sepsis: multiple modifications at multiple levels.
@en
prefLabel
Statins and sepsis: multiple modifications at multiple levels.
@en
P2093
P1476
Statins and sepsis: multiple modifications at multiple levels
@en
P2093
Daniel G Hackam
Robert S Rosenson
Terry S Smith
Yaniv Almog
P304
P356
10.1016/S1473-3099(07)70111-1
P577
2007-05-01T00:00:00Z